ALX ONCOLOGY HOLDINGS INC stock forecast: down to 5.76 USD ALXO stock price prognosis


Forecast for Fri 17 Nov 2023 price 6.98

ALX ONCOLOGY HOLDINGS INC stock price forecast for further price development down to -21.00% (time horizon: 1 day) and price target of 5.76 USD. Short-term (time horizon: 2 weeks) ALX ONCOLOGY HOLDINGS INC share price prediction for 2023-11-17 with daily closed price projections

Key Facts

Symbol ALXO 

ISIN US00166B1052 

CUSIP 00166B105

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

Finance numbers

Revenue 0.0

Earnings per share 3.67

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

We plan to initiate additional studies in combination with leading anti-cancer agents. These trials will be conducted in collaboration with Merck. Existing anti-cancer therapeutics can increase "eat me" signals on cancer cells. Overlapping toxicities of these agents dictate which agents can and cannot be combined. Moreover, many combinations are precluded entirely due to overlapping toxicity. The ORR reported in the lower dose 10 mg/kg QW cohort was 40.9% (9/22). & & Single-agent azacitidine is one of the few FDA-approved agents for patients with MDS. Treatment goals for patients with lower-risk MDS are different. Preliminary data for this cohort was also presented at SITC 2020. Subject response was evaluated based on RECIST version 1.1. As of October 1, 2020, five subjects had been dosed and four were response evaluable. Outcomes The primary objective of the trial was to assess safety. Notes: Data Cutoff October 1, 2020. The first part of the trial will evaluate the safety of the combination treatment. SIRPα TRAAC is complementary to our CD47 blocker approach. However, we believe that we do not infringe claims listed in this U.S. patent. These so-called Phase 4 trials may be made a condition to approval of the BLA. As of December 31, 2020, we had an accumulated deficit of $118.5 million. A failure of one or more clinical trials can occur at any stage of the process. Clinical trials can take many years to complete, and their ultimate outcome is uncertain. The development and commercialization of new product candidates is highly competitive. If they are unable to do so, it could have a material adverse impact on our business. For example, these third parties may be adversely impacted by the COVID-19 pandemic. We may face difficulties from changes to current regulations and future legislation. Other states are beginning to consider and pass similar laws. Litigation may be necessary to defend against these claims. Such license may not be available on commercially reasonable terms or at all. We currently have no products that have been approved for commercial sale. Collaborations are complex and time-consuming to negotiate and document. Therefore, these provisions could adversely affect the price of our common stock.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 39.06/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 17168
China Universal Asset Management Co., Ltd. 2023-06-30 536
MetLife Investment Management, LLC 2022-12-31 11755
MetLife Investment Management, LLC 2022-09-30 11755
MetLife Investment Management, LLC 2022-03-31 10745

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2023-02-28 22550 Long
Fidelity Advisor Series I 2023-02-28 25200 Long
Fidelity Concord Street Trust 2023-02-28 108907 Long
Fidelity Summer Street Trust 2023-02-28 10700 Long
Fidelity Advisor Series I 2023-02-28 653300 Long

Bollinger Bollinger Bands for ALX ONCOLOGY HOLDINGS INC can provide the information where the market is moving based on price information.

ALX ONCOLOGY HOLDINGS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns ALX ONCOLOGY HOLDINGS INC.

On-Balance Volume information for ALX ONCOLOGY HOLDINGS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for ALX ONCOLOGY HOLDINGS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for ALX ONCOLOGY HOLDINGS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for ALX ONCOLOGY HOLDINGS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for ALX ONCOLOGY HOLDINGS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for ALX ONCOLOGY HOLDINGS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for ALX ONCOLOGY HOLDINGS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-10-13 5.76 2023-09-23 09:10
2023-09-29 5.40 2023-09-23 09:10
2023-10-04 5.50 2023-09-23 09:10
2023-09-25 5.14 2023-09-23 09:10
2023-09-26 5.19 2023-09-23 09:10
2023-10-20 6.02 2023-09-23 09:10
2023-10-05 5.54 2023-09-23 09:10
2023-10-02 5.35 2023-09-23 09:10
2023-11-08 6.65 2023-09-23 09:10
2023-11-10 6.73 2023-09-23 09:10
2023-11-02 6.45 2023-09-23 09:10
2023-09-27 5.26 2023-09-23 09:10
2023-09-28 5.33 2023-09-23 09:10
2023-10-06 5.52 2023-09-23 09:10
2023-10-11 5.65 2023-09-23 09:10
2023-10-09 5.57 2023-09-23 09:10
2023-10-10 5.62 2023-09-23 09:10
2023-10-23 6.07 2023-09-23 09:10
2023-10-24 6.10 2023-09-23 09:10
2023-11-03 6.49 2023-09-23 09:10
2023-10-27 6.25 2023-09-23 09:10
2023-11-09 6.69 2023-09-23 09:10
2023-10-25 6.15 2023-09-23 09:10
2023-10-03 5.43 2023-09-23 09:10
2023-10-12 5.67 2023-09-23 09:10
2023-10-16 5.83 2023-09-23 09:10
2023-10-17 5.88 2023-09-23 09:10
2023-10-18 5.92 2023-09-23 09:10
2023-10-19 5.96 2023-09-23 09:10
2023-10-26 6.21 2023-09-23 09:10
2023-11-06 6.54 2023-09-23 09:10
2023-11-07 6.60 2023-09-23 09:10
2023-10-30 6.29 2023-09-23 09:10
2023-10-31 6.34 2023-09-23 09:10
2023-11-01 6.39 2023-09-23 09:10
2023-11-16 6.92 2023-09-23 09:10
2023-11-15 6.88 2023-09-23 09:10
2023-11-13 6.78 2023-09-23 09:10
2023-11-14 6.84 2023-09-23 09:10
2023-11-17 6.98 2023-09-23 09:10

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.